Moberg Derma (Nalox) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Asset Purch.
  • Financing Rounds
  • 1

Moberg Derma (Nalox) General Information

Description

Licensing rights of Nalox in Nordic region. Meda acquired the licensing rights to sell Nalox in to Russia, Turkey and several countries in Eastern Europe. Natok is used for the treatment of discolored and damaged nails caused by nail fungus or nail psoriasis.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Acquirer
Meda
Primary Office
  • Gustavslundsvägen 42, 5 tr.
  • 167 51 Bromma
  • Sweden
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Moberg Derma (Nalox) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Moberg Derma (Nalox)‘s full profile, request access.

Request a free trial

Moberg Derma (Nalox) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Moberg Derma (Nalox)‘s full profile, request access.

Request a free trial